Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

REVIEW ON SYNTHESIS SCHEMES OF FIRST LINE DRUGS OF ANTITUBERCULAR DRUGS

Vishal Sahu, Vishal Kushwaha, Vijay Sahu, Satyam Shukla, Imran Khan*

Adina Institute of Pharmaceutical Sciences, Sagar (M.P.)

ABSTRACT

Tuberculosis (TB) is an infectious disease caused by a variety of mycobacterium strains, the most prevalent of which being Mycobacterium tuberculosis. M. tuberculosis, M. africanum, M. bovis, and the Bacillus Calmette-Guérin strain, M. microti, M. canettii, M. caprae, M. pinnipedii, and M. mungi are all members of the M. tuberculosis complex. Other than M. tuberculosis complex, other species (M. avium complex, M. gordonae, M. kansasii, M. simiae, M. chelonae, M. fortuitum, etc.) do not cause tuberculosis in humans. TB mainly affects the lungs but can also affect other regions of the body. For many years, it was thought to be a poverty disease due to its rarity in developed countries. The present review focus on some synthesis schemes of first line drugs of antitubercular drugs.

Keywords: Antitubercular, Synthesis Schemes, Review


[Full Text Article]